ID: ALA4067765

Max Phase: Preclinical

Molecular Formula: C28H48N2O3

Molecular Weight: 460.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCCc1nc(OC2CCC2)nc(OC2CCC2)c1O

Standard InChI:  InChI=1S/C28H48N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-22-25-26(31)27(32-23-18-16-19-23)30-28(29-25)33-24-20-17-21-24/h23-24,31H,2-22H2,1H3

Standard InChI Key:  OGUVBXIMYFXHBC-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 460.70Molecular Weight (Monoisotopic): 460.3665AlogP: 8.07#Rotatable Bonds: 19
Polar Surface Area: 64.47Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.55CX Basic pKa: 3.97CX LogP: 9.58CX LogD: 9.58
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.21Np Likeness Score: 0.15

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source